GRADE 3A FOLLICULAR LYMPHOMA
Clinical trials for GRADE 3A FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new GRADE 3A FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for GRADE 3A FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to outsmart tough lymphoma
Disease control Recruiting nowThis study tests two drugs, pirtobrutinib and mosunetuzumab, together in 22 adults with a type of slow-growing lymphoma (grades 1-3a) that came back or didn't respond to at least two prior treatments. Pirtobrutinib blocks a protein that helps cancer grow, while mosunetuzumab help…
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New Low-Dose drug shows promise for untreated lymphoma patients
Disease control Recruiting nowThis study tests whether a low dose of the drug mosunetuzumab is safe and works well for people with slow-growing B-cell lymphoma (a type of blood cancer) that has not been treated before. About 20 adults with stage II to IV follicular or marginal zone lymphoma will receive the d…
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
New drug combo shows promise for untreated lymphoma patients
Disease control Recruiting nowThis study tests a combination of two drugs, acalabrutinib and obinutuzumab, in people with untreated slow-growing lymphomas like follicular lymphoma. The goal is to see if this treatment can shrink or control the cancer. About 49 adults will take part, and researchers will monit…
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 05, 2026 12:09 UTC